Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Testosterone undecanoate versus placebo for liver fat in hypogonadal overweight or obese men with type 2 diabetes or prediabetes
2017-001611-37Phase 4Active
- Sponsor
- Medical University of Vienna
- Start
- Nov 2018
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of testosterone undecanoate in Hypoandrogenism (TD) (3 arms), sponsored by Medical University of Vienna. Primary endpoint: Change in liver fat content. Started Nov 2018; status: active.
02
Drugs
testosterone undecanoate
03
Conditions
Hypoandrogenism (TD)
Beyond the preview
Go deeper on 2017-001611-37.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2017-001611-37.